After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

An investigation by Democratic senators has raised concerns about conflicts of interest in telehealth companies' ties to ...

A High Rate of Prescriptions Are Written. The Report examined the number of prescriptions that resulted from patient participation in a Program, concluding that the rate was “high”. In one case, the ...

Several months after a group of senators sent letters to Pfizer and Eli Lilly investigating their respective direct-to-consumer telehealth platforms, the lawmakers are now directing similar ...

Eli Lilly & Co. is suing four telehealth companies selling compounded versions of tirzepatide, the active ingredient in Lilly's weight-loss drug Zepbound and diabetes drug Mounjaro.

Hims & Hers Health Inc. shares slid over 2.8% on Tuesday and continued declining after-hours trading after Eli Lilly clarified that it would not partner with telehealth firms offering compounded ...